Lisi (XPAR:FII) Change In Receivables : €0 Mil (TTM As of Dec. 2023)

View and export this data going back to 1989. Start your Free Trial

What is Lisi Change In Receivables?

Lisi's change in receivables for the quarter that ended in Dec. 2023 was €0 Mil. It means Lisi's Accounts Receivable stayed the same from Jun. 2023 to Dec. 2023 .

Lisi's change in receivables for the fiscal year that ended in Dec. 2023 was €0 Mil. It means Lisi's Accounts Receivable stayed the same from Dec. 2022 to Dec. 2023 .

Lisi's Accounts Receivable for the quarter that ended in Dec. 2023 was €226 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Lisi's Days Sales Outstanding for the six months ended in Dec. 2023 was 48.18.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Lisi's liquidation value for the six months ended in Dec. 2023 was €-592 Mil.

Lisi Change In Receivables Historical Data

The historical data trend for Lisi's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lisi Change In Receivables Chart

Lisi Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

Lisi Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Lisi Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0 Mil.

Lisi (XPAR:FII) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Lisi's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	226.137	/	856.58	*	91
=	48.18

2. In Ben Graham's calculation of liquidation value, Lisi's accounts receivable are only considered to be worth 75% of book value:

Lisi's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	139.312	-	1119.83	+	0.75 * 226.137	+	0.5 * 437.323
=	-592

Lisi Change In Receivables Related Terms

Thank you for viewing the detailed overview of Lisi's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Lisi (XPAR:FII) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Aerospace & Defense » Lisi SA (XPAR:FII) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

LSIIF:USA 0EKE:UK LI3:Germany

Address

6 Rue Juvenal Viellard, Grandvillars, Belfort Cedex, CS 70431, Belfort, FRA, 90008

Website

https://www.lisi-group.com

Lisi SA primarily designs, manufactures, and markets fasteners and other components for the aerospace and vehicular sectors. The company has three operating segments: Aerospace, Automotive, and Medical. Products are manufactured to serve as original or replacement equipment. They are distributed internationally and may undergo customization for Lisi's major clients. The Medical segment creates fasteners, implants, and other instruments to help support the human body, and is responsible for roughly 5% of sales. France accounts for roughly one third of sales, European Union accounts for another one third of sales, and the rest of the world makes up the remainder.

Lisi (XPAR:FII) Headlines

No Headlines